Kaplan-Meier estimates of mortality, loss to follow-up, transfer out, stopping ART medication and attrition from care after ART initiation
| Months of follow-up | Cumulative events, n | Mortality, n; % (95% CI) | Loss to follow-up, n; % (95% CI) | Transfer-out, n; % (95% CI) | Stopping ART, n; % (95% CI) | Attrition, % (95% CI) |
| 6 months | 128 | 30; 2.6 (1.6 to 3.6) | 37; 3.2 (2.2 to 4.2) | 54; 4.6 (3.4 to 5.8) | 7.0; 0.6 (0.2 to 1.0) | 10.7 (8.9 to 12.5) |
| 12 months | 193 | 45; 4.0 (2.8 to 5.2) | 54; 4.8 (3.6 to 6.0) | 83; 7.3 (5.7 to 8.9) | 11; 1.0 (0.4 to 1.6) | 16.0 (13.8 to 18.2). |
| 18 months | 213 | 45; 4.0 (2.8 to 5.2) | 64; 5.8 (4.4 to 7.2) | 93; 8.2 (6.6 to 9.8) | 11; 1.0 (0.4 to 1.6) | 17.9 (15.7 to 20.1) |
| 24 months | 231 | 48; 4.4 (3.2 to 5.6) | 70; 6.8 (5.2 to 8.4) | 102; 9.5 (7.7 to 11.3) | 11; 1.0 (0.4 to 1.6) | 20.2 (17.8 to 22.6) |